Bellevue Healthcare Trust plc
BBH.L · LSE
5/31/2025 | 11/30/2024 | 5/31/2024 | 11/30/2023 | |
|---|---|---|---|---|
| Revenue | -£78 | £37 | £48 | -£66 |
| % Growth | -312.9% | -23.6% | 172.6% | – |
| Cost of Goods Sold | £1 | £3 | £3 | £4 |
| Gross Profit | £0 | £33 | £45 | -£69 |
| % Margin | -0% | 91% | 93.4% | 105.6% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | -£1 | £0 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £0 | £0 | -£1 | £0 |
| Operating Income | -£80 | £33 | £44 | -£70 |
| % Margin | 102.7% | 89.9% | 92.2% | 106.4% |
| Other Income/Exp. Net | £0 | -£1 | -£2 | -£2 |
| Pre-Tax Income | -£80 | £32 | £42 | -£72 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | -£80 | £32 | £42 | -£72 |
| % Margin | 102.8% | 86.9% | 87.9% | 110.1% |
| EPS | -0.33 | 0.069 | 0.091 | -0.13 |
| % Growth | -579% | -24.1% | 169.8% | – |
| EPS Diluted | -0.33 | 0.069 | 0.091 | -0.13 |
| Weighted Avg Shares Out | 241 | 460 | 462 | 549 |
| Weighted Avg Shares Out Dil | 241 | 460 | 462 | 549 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£80 | £33 | £44 | -£70 |
| % Margin | 102.7% | 90.5% | 92.2% | 106.4% |